Lysulin, Inc.

Calculating rank

Forward Citations = 1

Loading Chart...

1 inventor (with patents filed for the assignee):

John Burd (7 out of 18 patents)

7 patents: Sort by Forward Citations

1. 11255838 - Levels, functions, and resistances related to chronic conditions by using lysine-based supplements (2022-02-22),

2. 11045495 - Method of improving beta cell function using a supplement (2021-06-29),

3. 10980834 - Prevention of protein glycation using lysine supplements (2021-04-20),

4. 10656166 - Inhibiting chronic blood and nephrological disorders using lysine-based supplements (2020-05-19),

5. 10653720 - Prevention of protein glycation using lysine/zinc supplements (2020-05-19),

6. 10610544 - Insulin resistance and beta cell function using lysine-based supplements (2020-04-07),

7. 10466256 - Inhibiting chronic blood and nephrological disorders using lysine-based supplements (2019-11-05),

Company Overview

Lysulin, Inc. is a leading provider of nutritional supplements for people with diabetes. Their flagship product, Lysulin, is a patented formula that helps support healthy blood sugar levels and overall health. With a commitment to quality and innovation, Lysulin, Inc. is dedicated to improving the lives of those living with diabetes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#705 in San Diego, CA

#9,511 in California

#39,950 in US

San Diego, CA, United States of America

Lysulin, Inc.

Forward Citations = 1

1 inventor:

John Burd (7 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lysulin, Inc.. Retrieved from https://idiyas.com/company/lysulin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]